Page last updated: 2024-10-29

iohexol and Bright Disease

iohexol has been researched along with Bright Disease in 2 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Bright Disease: A historical classification which is no longer used. It described acute glomerulonephritis, acute nephritic syndrome, or acute nephritis. Named for Richard Bright.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brown, JR1
Solomon, RJ1
Smets, PM1
Lefebvre, HP1
Aresu, L1
Croubels, S1
Haers, H1
Piron, K1
Meyer, E1
Daminet, S1

Other Studies

2 other studies available for iohexol and Bright Disease

ArticleYear
Contrast-induced nephropathy morbidity and mortality following percutaneous coronary intervention.
    The American journal of cardiology, 2009, Dec-15, Volume: 104, Issue:12

    Topics: Angioplasty, Balloon, Coronary; Contrast Media; Female; Glomerulonephritis; Humans; Iohexol; Male

2009
Renal function and morphology in aged Beagle dogs before and after hydrocortisone administration.
    PloS one, 2012, Volume: 7, Issue:2

    Topics: Animals; Atrophy; Biopsy; Creatinine; Disease Models, Animal; Dogs; Enzyme-Linked Immunosorbent Assa

2012